Veracyte, Inc.
VCYT- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001384101
In the last 90 days, Veracyte, Inc. insiders filed 0 open-market purchases and 6 sales; 370 institutions reported holding it in 13F filings for Q2 2026, worth $5.23B in total; ARK Invest is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Veracyte, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 232 | 4 | 237 | +9 |
| Shares | 77.1M | 473.2K | 76.6M | +36.6K (0.0%) |
| Value | $1.96B | $12.0M | $1.72B | −$234.2M (−12.0%) |
4 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (28)
Institutions that held Veracyte, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (19)
Institutions that held Veracyte, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Candriam Luxembourg S.C.A. | 600,926 | $15.3M |
| Clough Capital Partners L P | 276,260 | $7.04M |
| Stephens Inc | 37,577 | $957.1K |
| Tudor Investment Corp Et Al | 33,950 | $864.7K |
| Vident Investment Advisory, LLC | 12,214 | $311.0K |
| NinePointTwo Capital | 10,437 | $265.0K |
| TownSquare Capital, LLC | 9,937 | $253.1K |
| Verition Fund Management LLC | 9,925 | $252.8K |
| Yarbrough Capital, LLC | 9,796 | $249.5K |
| Two Sigma Investments, LP | 9,000 | $229.2K |
| FDx Advisors, Inc. | 8,586 | $219.0K |
| Amundi | 3,500 | $87.2K |
| Harbor Capital Advisors, Inc. | 1,500 | $38.2K |
| Pinebridge Investments, L.P. | 816 | $20.8K |
| Quent Capital, LLC | 500 | $12.7K |
| Signaturefd, LLC | 274 | $6.98K |
| Concord Wealth Partners | 69 | $1.76K |
| Impact Partnership Wealth, LLC | 48 | $1.22K |
| Disciplined Investments, LLC | 3 | $76 |
Not filed for Q3 2023 yet (4)
Institutions that held Veracyte, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Kames Capital plc | 448,535 | $11.4M |
| Efg Capital International Corp. | 14,337 | $365.2K |
| Pictet Asset Management SA | 8,798 | $224.1K |
| BerganKDV Wealth Management, LLC | 1,500 | $38.2K |